JPH0577644B2 - - Google Patents
Info
- Publication number
- JPH0577644B2 JPH0577644B2 JP59161134A JP16113484A JPH0577644B2 JP H0577644 B2 JPH0577644 B2 JP H0577644B2 JP 59161134 A JP59161134 A JP 59161134A JP 16113484 A JP16113484 A JP 16113484A JP H0577644 B2 JPH0577644 B2 JP H0577644B2
- Authority
- JP
- Japan
- Prior art keywords
- zinc oxide
- sodium
- oxide powder
- fine
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 28
- 239000010419 fine particle Substances 0.000 claims description 24
- 239000002537 cosmetic Substances 0.000 claims description 23
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 15
- 239000003945 anionic surfactant Substances 0.000 claims description 9
- 239000011592 zinc chloride Substances 0.000 claims description 8
- 235000005074 zinc chloride Nutrition 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 7
- 229960001763 zinc sulfate Drugs 0.000 claims description 7
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 3
- 238000011010 flushing procedure Methods 0.000 claims description 2
- 239000011734 sodium Substances 0.000 description 13
- 229910052708 sodium Inorganic materials 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 230000006750 UV protection Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 150000008051 alkyl sulfates Chemical class 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000519995 Stachys sylvatica Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 3
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- -1 etc. Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- JFWPGOZRLLZFPL-RMRYJAPISA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-(hexadecanoylamino)butanedioic acid Chemical compound OCCN(CCO)CCO.OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(O)=O JFWPGOZRLLZFPL-RMRYJAPISA-N 0.000 description 1
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- WKCCHCOTEVHSER-UHFFFAOYSA-L disodium propane-1,2,3-triol sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.OCC(O)CO WKCCHCOTEVHSER-UHFFFAOYSA-L 0.000 description 1
- 229940079784 disodium stearoyl glutamate Drugs 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940077092 sodium myristoyl glutamate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- FCBUGCHAVCFTHW-NTISSMGPSA-N sodium;(2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound [Na].CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O FCBUGCHAVCFTHW-NTISSMGPSA-N 0.000 description 1
- HJXBXTZDPSSEST-UHFFFAOYSA-M sodium;2-[methyl(tetradecanoyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O HJXBXTZDPSSEST-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は化粧料、さらに詳しくは微粒子酸化亜
鉛粉末を系中に含有してなる、分散安定性良好
で、皮膚に塗布したときに透明感を有しているの
で白つぽくならず、かつ紫外線防止効果を有し、
消炎・殺菌効果をも併せもつ優れた化粧料に関す
る。Detailed Description of the Invention [Industrial Field of Application] The present invention relates to a cosmetic, more specifically, a cosmetic containing fine-particle zinc oxide powder, which has good dispersion stability and has a transparent appearance when applied to the skin. It does not cause white spots and has UV protection effect.
This article relates to excellent cosmetics that also have anti-inflammatory and sterilizing effects.
[従来の技術]
従来、化粧料に配合される粉末は一般的には粒
径0.5μ程度のものであり、最も粒径の小さいもの
でも300〜400Å程度の酸化チタンが知られている
のみであつた(特公昭47−42502号公報)。[Prior art] Powders used in cosmetics have generally had a particle size of about 0.5μ, and titanium oxide, which has the smallest particle size of about 300 to 400Å, is only known. Atsuta (Special Publication No. 47-42502).
[発明が解決しようとする問題点]
配合粉末の粒径が上記の通り300〜400Å程度以
上であると、皮膚に塗布した場合にはどうしても
白つぽさが目立ち、不自然な感じになることは否
めない。このため、紫外線防止効果を付与したり
肌にさつぱり感を与えたりせんがために化粧料中
に粉末を配合しようとするときにも、この白つぽ
さが大いに障害となつていた。[Problems to be solved by the invention] As mentioned above, if the particle size of the blended powder is about 300 to 400 Å or more, when applied to the skin, white spots will be noticeable and it will look unnatural. I can't deny it. For this reason, this whiteness has been a major obstacle when trying to incorporate powder into cosmetics to provide UV protection or give a refreshing feeling to the skin.
本発明者らはこうした現状にかんがみ、酸化亜
鉛に着目し鋭意検討した結果、このものを微粒子
化して化粧料基剤中に配合すれば、上記欠点を解
決しうることを見いだし、もつて本発明をなすに
至つたのである。 In view of the current situation, the present inventors focused on zinc oxide and, as a result of intensive study, discovered that the above-mentioned drawbacks could be solved by making this material into fine particles and blending it into a cosmetic base. This is what we came to do.
[問題点を解決するための手段]
すなわち、本発明は微粒子酸化亜鉛粉末を含有
することを特徴とする化粧料である。[Means for Solving the Problems] That is, the present invention is a cosmetic characterized by containing fine-particle zinc oxide powder.
以下、本発明の構成について詳述する。 Hereinafter, the configuration of the present invention will be explained in detail.
本発明で用いる微粒子酸化亜鉛粉末は粒径10〜
200Å(平均粒径50Å超上100Å未満)の微粒子酸
化亜鉛粉末であり、機械的粉砕などによつても得
ることができるが、製造の容易さ、得られた微粒
子粉末の化粧料基剤中への分散性の良さ、粒径の
均一なことから、水溶液中で調整した硫酸亜鉛も
しくは塩化亜鉛のヒドロゾル中のコロイド粒子を
陰イオン界面活性剤で親油的に転換したのち、有
機溶媒にてフラツシングし、ついで該有機溶媒を
乾燥除去して得られる微粒子酸化亜鉛粉末がとく
に好ましい。上記コロイドゾル(以下、ゾル法と
いう)を経て得られる微粒子酸化亜鉛粉末の粒径
は10〜200Åの範囲、一般的には50〜100Åの範囲
に分布し、平均粒径では50Å超100Å未満の範囲
に存する。 The fine particle zinc oxide powder used in the present invention has a particle size of 10~
It is a fine-particle zinc oxide powder with an average particle size of 200 Å (more than 50 Å and less than 100 Å), and can be obtained by mechanical grinding, etc., but it is easy to manufacture and it is difficult to incorporate the obtained fine-particle powder into a cosmetic base. Because of its good dispersibility and uniform particle size, colloidal particles in a hydrosol of zinc sulfate or zinc chloride prepared in an aqueous solution are converted into lipophilic particles with an anionic surfactant, and then flushed with an organic solvent. Particularly preferred is a fine-particle zinc oxide powder obtained by then drying and removing the organic solvent. The particle size of the fine zinc oxide powder obtained through the above colloidal sol (hereinafter referred to as the sol method) is distributed in the range of 10 to 200 Å, generally in the range of 50 to 100 Å, and the average particle size is in the range of more than 50 Å and less than 100 Å. exists in
ゾル法についてさらに詳しく説明する。 The sol method will be explained in more detail.
この方法においては、まず、塩化亜鉛もしくは
硫酸亜鉛水溶液中に炭酸ナトリウム水溶液を添加
してヒドロゾルを形成する。塩化亜鉛もしくは硫
酸亜鉛水溶液の濃度は0.1〜1.0モル程度、炭酸ナ
トリウム水溶液の濃度は0.2〜1.0モル程度、塩化
亜鉛もしくは硫酸亜鉛水溶液:炭酸ナトリウム水
溶液の比率は重量比で1:1程度である。 In this method, first, an aqueous sodium carbonate solution is added to an aqueous solution of zinc chloride or zinc sulfate to form a hydrosol. The concentration of the zinc chloride or zinc sulfate aqueous solution is about 0.1 to 1.0 mol, the concentration of the sodium carbonate aqueous solution is about 0.2 to 1.0 mol, and the ratio of the zinc chloride or zinc sulfate aqueous solution to the sodium carbonate aqueous solution is about 1:1 by weight.
つぎに、陰イオン界面活性剤を加えて該ヒドロ
ゾルを親油化する。用いられる陰イオン界面活性
剤はアルキルベンゼンスルフオン酸ナトリウム、
ラウリル硫酸ナトリウム、ラウリル硫酸カリウ
ム、アルキル硫酸トリエタノールアミンエーテ
ル、ロート油、ジアルキルスルフオサクシネート
ナトリウム、ジ2エチルヘキシルスルフオサクシ
ネートナトリウム、ラウリルポリエチレングリコ
ールスルフオサクシネートナトリウム、アルキル
エーテルサルフエートナトリウム、ポリオキシエ
チレン(以下、POEという)アルキル硫酸ナト
リウム、N−パルミトイルアスパラギン酸ジトリ
エタノールアミン、ヤシ油脂肪酸メチルタウリド
ナトリウム、ミリストイルメチルタウリンナトリ
ウム、ラウリルメチルタウリドナトリウム、ラウ
ロイルグルタミン酸ナトリウム、酸化ヤシ油脂肪
酸グリセリン硫酸ナトリウム、ステアロイルグル
タミン酸ジナトリウム、ミリストイルグルタミン
酸ナトリウム、POEアルキルフエニルエーテル
硫酸ナトリウム、POEアルキル硫酸トリエタノ
ールアミン、ラウロイルザルコシンナトリウム、
カゼインナトリウム、パルミチン酸ナトリウム、
ラウリン酸ナトリウム、POE硬化ヒマシ油マレ
イン酸エステルなどであるが、とくにアルキルベ
ンゼンスルフオン酸ナトリウム、ラウリル硫酸ナ
トリウム、ラウリル硫酸カリウム、アルキル硫酸
トリエタノールアミンエーテルが好ましい。陰イ
オン界面活性剤の添加量は塩化亜鉛もしくは硫酸
亜鉛と炭酸ナトリウムとの量比によつても異なる
が、おおむね塩化亜鉛もしくは硫酸亜鉛1モルに
対して0.05〜0.15モルの範囲で選択すれば良い。 Next, an anionic surfactant is added to make the hydrosol lipophilic. The anionic surfactant used is sodium alkylbenzene sulfonate,
Sodium lauryl sulfate, potassium lauryl sulfate, alkyl sulfate triethanolamine ether, funnel oil, sodium dialkyl sulfosuccinate, sodium di2ethylhexyl sulfosuccinate, sodium lauryl polyethylene glycol sulfosuccinate, sodium alkyl ether sulfate, poly Sodium oxyethylene (hereinafter referred to as POE) alkyl sulfate, N-palmitoylaspartate ditriethanolamine, sodium coconut oil fatty acid methyltauride, sodium myristoylmethyltaurate, sodium lauryl methyltauride, sodium lauroyl glutamate, oxidized coconut oil fatty acid glycerin sulfate Sodium, disodium stearoyl glutamate, sodium myristoyl glutamate, POE sodium alkyl phenyl ether sulfate, POE alkyl sulfate triethanolamine, sodium lauroyl sarcosine,
sodium caseinate, sodium palmitate,
Examples include sodium laurate, POE hydrogenated castor oil maleate, and particularly preferred are sodium alkylbenzenesulfonate, sodium lauryl sulfate, potassium lauryl sulfate, and alkyl sulfate triethanolamine ether. The amount of anionic surfactant added varies depending on the ratio of zinc chloride or zinc sulfate to sodium carbonate, but it should generally be selected in the range of 0.05 to 0.15 mol per 1 mol of zinc chloride or zinc sulfate. .
本発明に係るゾル法にあつては、上記陰イオン
界面活性剤の親水性、親油性のバランスなどを適
宜選択することにより、得られる微粒子酸化亜鉛
粉末を親水性にも親油性にも調整することができ
る。たとえば、微粒子酸化亜鉛粉末を水性基剤の
化粧料中に配合しようとするときには陰イオン界
面活性剤としてラウリル硫酸ナトリウム、ラウリ
ル硫酸カリウム、アルキル硫酸トリエタノールア
ミンエーテルなどを用いると親水性の微粒子酸化
亜鉛粉末が得られる。また、陰イオン界面活性剤
としてアルキルベンゼンスルフオン酸ナトリウム
などを用いると親油性の微粒子酸化亜鉛粉末が得
られるので油性基剤の化粧料に配合するのに好適
である。 In the sol method according to the present invention, the obtained fine particle zinc oxide powder is adjusted to be either hydrophilic or lipophilic by appropriately selecting the balance between hydrophilicity and lipophilicity of the anionic surfactant. be able to. For example, when blending fine-particle zinc oxide powder into aqueous-based cosmetics, it is recommended to use sodium lauryl sulfate, potassium lauryl sulfate, alkyl sulfate triethanolamine ether, etc. as anionic surfactants to form hydrophilic fine-particle zinc oxide powder. A powder is obtained. Furthermore, when sodium alkylbenzenesulfonate or the like is used as an anionic surfactant, lipophilic fine particle zinc oxide powder can be obtained, which is suitable for blending into oil-based cosmetics.
親油化された該ヒドロゾルは、次に有機溶媒で
フラツシングされる。用いられる有機溶媒は上記
陰イオン界面活性剤を溶解するものであれば何で
もよい。たとえば、キシレン、トルエン、ベンゼ
ンなどやこれらの混合溶媒が用いられる。有機溶
媒の量はヒドロゾル溶液に対して重量比で0.5〜
1.0倍量程度の範囲で選択される。 The lipophilized hydrosol is then flushed with an organic solvent. Any organic solvent may be used as long as it dissolves the anionic surfactant. For example, xylene, toluene, benzene, etc., and a mixed solvent thereof are used. The amount of organic solvent is 0.5 to 0.5 to the hydrosol solution by weight.
Selected within a range of approximately 1.0 times the amount.
こうして得られたオルガノゾルは乾燥して微粒
子酸化亜鉛粉末を分取する。乾燥方法はとくに制
限はなく、常法に従えば良い。 The organosol thus obtained is dried to separate fine particles of zinc oxide powder. There are no particular restrictions on the drying method, and any conventional method may be used.
本発明にあつては、微粒子酸化亜鉛粉末は化粧
料全量中の0.5〜100重量%、紫外線防止効果の面
からは10重量%以上、肌にさつぱりした効果をあ
たえる観点からは50重量%以上配合されることが
好ましい。 In the present invention, the fine particle zinc oxide powder is 0.5 to 100% by weight of the total amount of the cosmetic, 10% by weight or more from the perspective of UV protection, and 50% by weight from the perspective of providing a refreshing effect on the skin. It is preferable that the above components be blended.
本発明の微粒子酸化亜鉛粉末を含有してなる化
粧料の剤型は任意であり、広く粉末系、可溶化
系、乳化系、粉末分散可溶化系、粉末分散乳化
系、粉末分散油系などをとることができる。 The dosage form of the cosmetic containing the fine-particle zinc oxide powder of the present invention is arbitrary, and broadly includes powder-based, solubilized-based, emulsified-based, powder-dispersed-solubilized, powder-dispersed-emulsified, powder-dispersed oil-based, etc. You can take it.
用途も任意であり、化粧水、乳液、クリーム、
化粧油などのフエーシヤル化粧料をはじめ、フア
ンデーシヨン、パウダー、口紅、頬紅、アイシヤ
ドーなどのメーキヤツプ化粧料などの広範な化粧
料に用いることができる。 The use is also optional, such as lotion, emulsion, cream,
It can be used in a wide range of cosmetics, including facial cosmetics such as cosmetic oils, and makeup cosmetics such as foundations, powders, lipsticks, blushers, and eye shadows.
[発明の効果]
本発明に係る微粒子酸化亜鉛粉末含有化粧料
は、良好な透明感を有しているので肌に塗布した
ときの白つぽさもなくかつ紫外線防止効果に優
れ、肌にさつぱりとした使用感を与え、また化粧
料基剤中での分散安定性も良好である。さらに、
粉末であるがために液状の紫外線吸収剤のような
肌に対する刺激、アレルギーなどの心配もない。
安全性良好な化粧料である。[Effects of the Invention] The cosmetic containing fine-particle zinc oxide powder according to the present invention has a good transparency, so when applied to the skin, there is no whiteness, and it has an excellent ultraviolet ray prevention effect, and is gentle on the skin. It gives a crisp feeling on use and also has good dispersion stability in cosmetic bases. moreover,
Since it is a powder, there is no need to worry about skin irritation or allergies like with liquid UV absorbers.
It is a cosmetic with good safety.
[実施例]
次に、本発明の微粒子酸化亜鉛粉末の製造例お
よび微粒子酸化亜鉛粉末を化粧料中に配合した実
施例を示す。本発明はこれにより限定されるもの
ではない。[Example] Next, an example of manufacturing a particulate zinc oxide powder of the present invention and an example in which the particulate zinc oxide powder was blended into a cosmetic will be shown. The present invention is not limited thereby.
製造例 1
1M塩化亜鉛水溶液中に0.1M炭酸ナトリウム水
溶液を1:1の重量比で添加する。添加速度は25
ml/min.の割合とした。30分間撹拌を続け白色
のヒドロゾルを得たのち、アルキルベンゼンスル
フオン酸ナトリウムを0.15M加えてゾルを親油化
し、ついでキシレンを25ml加えてフラツシング
し、白色のオルガノゾルを得た。このものを減圧
下で乾燥してキシレンを留去して粒径70〜100Å
の微粒子酸化亜鉛粉末1gを得た。この微粒子酸
化亜鉛粉末は親油性であり、油性化粧料への配合
に適する。Production Example 1 A 0.1M aqueous sodium carbonate solution is added to a 1M aqueous zinc chloride solution at a weight ratio of 1:1. Addition rate is 25
The ratio was expressed as ml/min. After stirring for 30 minutes to obtain a white hydrosol, 0.15M sodium alkylbenzenesulfonate was added to make the sol lipophilic, and then 25 ml of xylene was added for flushing to obtain a white organosol. This material was dried under reduced pressure to remove xylene and the particle size was 70 to 100 Å.
1 g of fine particle zinc oxide powder was obtained. This fine-particle zinc oxide powder is lipophilic and suitable for blending into oil-based cosmetics.
製造例 2
製造例1のアルキルベンゼンスルフオン酸ナト
リウムをラウリル硫酸ナトリウムに置換した他は
製造例1と同様に製造して親水性の微粒子酸化亜
鉛粉末を得た。このものは水性化粧料への配合に
適する。Production Example 2 A hydrophilic fine-particle zinc oxide powder was obtained in the same manner as Production Example 1 except that the sodium alkylbenzenesulfonate in Production Example 1 was replaced with sodium lauryl sulfate. This product is suitable for blending into aqueous cosmetics.
実施例 1
(化粧水)
グリセリン 3.0重量%
プロピレングリコール 2.0
オレイルアルコール 0.1
POE(20)ソルビタンモノラウリン酸エステル
2.0
エタノール 10.0
香 料 0.1
染 料 適 量
微粒子酸化亜鉛粉末(製造例2で得たもの)
1.0
水 残 部
にを加え溶解する(水相部)。に
を溶解する(エタノール部)。水相部にエ
タノール部を加えて可溶化し、化粧水を得た。得
られた化粧水はさつぱりした使用感を持ち、肌に
塗布したときの白つぽさもなくて透明感も良好で
ありながら紫外線防止効果を有し、また、肌の消
炎効果にも優れていた。さらに、微粒子酸化亜鉛
粉末の粒径が細かいためにとくに増粘剤などを加
えなくとも分散性は良好であつた。Example 1 (Lotion) Glycerin 3.0% by weight Propylene glycol 2.0 Oleyl alcohol 0.1 POE(20) Sorbitan monolaurate
2.0 Ethanol 10.0 Flavor 0.1 Dye Appropriate amount Fine particle zinc oxide powder (obtained in Production Example 2)
Add 1.0% of water and dissolve (aqueous phase). (ethanol part). An ethanol portion was added to the aqueous phase for solubilization to obtain a lotion. The resulting lotion has a refreshing feel, does not leave any white spots when applied to the skin, has good transparency, has UV protection effects, and is also excellent in anti-inflammatory effects on the skin. was. Furthermore, since the particle size of the fine zinc oxide powder was small, the dispersibility was good even without adding a thickener or the like.
実施例 2
(日焼け止めクリーム)
ステアリン酸 10.0重量%
ステアリルアルコール 4.0
ステアリン酸ブチル 6.0
モノステアリン酸グリセリン(自己乳化型)
2.0
香 料 適量
プロピレングリコール 10.0
グリセリン 3.0
水酸化カリウム 0.4
微粒子酸化亜鉛粉末(製造例2で得たもの)
4.0
水 残部
にを加え溶解して70℃に保つ(水相
部)。を溶解して70℃に保つ(油相
部)。水相部に油相部を加えて乳化し、冷却して
クリームを得た。得られたクリームはとくに紫外
線防止効果に優れていた。Example 2 (Sunscreen cream) Stearic acid 10.0% by weight Stearyl alcohol 4.0 Butyl stearate 6.0 Glyceryl monostearate (self-emulsifying type)
2.0 Flavor Appropriate amount Propylene glycol 10.0 Glycerin 3.0 Potassium hydroxide 0.4 Fine particle zinc oxide powder (obtained in Production Example 2)
4.0 Add the remainder of the water, dissolve and keep at 70℃ (aqueous phase). Dissolve and keep at 70℃ (oil phase). The oil phase was added to the water phase, emulsified, and cooled to obtain cream. The resulting cream had particularly excellent UV protection effects.
実施例 3
(日焼け止め乳液)
ステアリン酸 2.0重量%
セタノール 1.5
ワセリン 3.0
流動パラフイン 8.0
POE(10)モノオレイン酸エステル 2.0
香料 適量
グリセリン 2.0
プロピレングリコール 5.0
トリエタノールアミン 1.0
(10) 微粒子酸化亜鉛粉末(製造例2で得たもの)
5.5
(11) 水 残部
(11)にを加え溶解して70℃に保つ(水相
部)。を溶解して70℃に保つ(油相
部)。水相部に油相部を加えて乳化し、冷却して
乳液を得た。得られた乳液はとくに紫外線防止効
果に優れており、また使用感もさつぱりしたもの
であつた。Example 3 (Sunscreen emulsion) Stearic acid 2.0% by weight Setanol 1.5 Vaseline 3.0 Liquid paraffin 8.0 POE(10) monooleate 2.0 Fragrance Appropriate amount Glycerin 2.0 Propylene glycol 5.0 Triethanolamine 1.0 (10) Fine particle zinc oxide powder (manufacturing example What you got in 2)
5.5 (11) Water Add the remaining part (11) and dissolve and keep at 70℃ (water phase). Dissolve and keep at 70℃ (oil phase). The oil phase was added to the water phase, emulsified, and cooled to obtain a milky lotion. The resulting emulsion had particularly excellent UV protection effects, and also had a refreshing feel upon use.
実施例 4
(フアンデーシヨン)
ステアリン酸 2.8重量%
モノステアリン酸プロピレングリコール
2.8
モノステアリン酸グリセリン(自己乳化型)
2.8
流動パラフイン 24.6
トリエタノールアミン 1.4
プロピレングリコール 15.0
微粒子酸化亜鉛粉末(製造例1で得たもの)
6.0
酸化鉄赤 1.5
酸化鉄黄 2.5
香料 適量
防腐剤 適量
水 残部
にを加え溶解して70℃に保つ(水相
部)。を溶解してこれにを分
散し70℃にて保つ(油相部)。水相部に油相部を
加えて乳化し、冷却してフアンデーシヨンを得
た。Example 4 (Foundation) Stearic acid 2.8% by weight Propylene glycol monostearate
2.8 Glyceryl monostearate (self-emulsifying type)
2.8 Liquid paraffin 24.6 Triethanolamine 1.4 Propylene glycol 15.0 Fine particle zinc oxide powder (obtained in Production Example 1)
6.0 Iron oxide red 1.5 Iron oxide yellow 2.5 Add an appropriate amount of fragrance, an appropriate amount of preservative, and the remainder of water to dissolve and keep at 70℃ (aqueous phase). Dissolve and disperse in this and keep at 70℃ (oil phase). The oil phase was added to the water phase, emulsified, and cooled to obtain a foundation.
実施例 5
(白粉)
タルク 10.2重量%
酸化チタン 10
微粒子酸化亜鉛粉末(製造例1で得たもの)
77.0
酸化鉄赤黄黒 1.8
酸化鉄黄 2.5
香料 適量
上記成分を混合して白粉を得た。このものは肌
に塗布したときに透明感が良好で白つぽくなら
ず、化粧抑え効果にもすぐれていた。また、紫外
線防止効果も充分であつた。Example 5 (white powder) Talc 10.2% by weight Titanium oxide 10 Fine particle zinc oxide powder (obtained in Production Example 1)
77.0 Iron oxide red yellow black 1.8 Iron oxide yellow 2.5 Flavor appropriate amount The above ingredients were mixed to obtain white powder. When applied to the skin, this product had good transparency, did not leave a white appearance, and had an excellent makeup-reducing effect. In addition, the UV protection effect was sufficient.
Claims (1)
鉛のヒドロゾル中のコロイド粒子を陰イオン界面
活性剤で親油的に転換したのち有機溶媒でフラツ
シングしついで当該有機溶媒を乾燥除去して得ら
れる平均粒径50Å超100Å未満の微粒子酸化亜鉛
粉末を含有することを特徴とする化粧料。1 Average particle size obtained by converting colloidal particles in a hydrosol of zinc sulfate or zinc chloride prepared in an aqueous solution into lipophilic form with an anionic surfactant, flushing with an organic solvent, and removing the organic solvent by drying. A cosmetic comprising fine particle zinc oxide powder with a particle size of more than 50 Å and less than 100 Å.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16113484A JPS6137711A (en) | 1984-07-31 | 1984-07-31 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16113484A JPS6137711A (en) | 1984-07-31 | 1984-07-31 | Cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6137711A JPS6137711A (en) | 1986-02-22 |
JPH0577644B2 true JPH0577644B2 (en) | 1993-10-27 |
Family
ID=15729241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16113484A Granted JPS6137711A (en) | 1984-07-31 | 1984-07-31 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6137711A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008273767A (en) * | 2007-04-26 | 2008-11-13 | Sakai Chem Ind Co Ltd | Method for producing zinc oxide and zinc oxide |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2593296B2 (en) * | 1985-10-08 | 1997-03-26 | 岡村製油株式会社 | Cosmetic composition and method for producing the same |
JPS63132821A (en) * | 1986-11-21 | 1988-06-04 | Shiseido Co Ltd | Anti-suntan cosmetic |
JPH072615B2 (en) * | 1986-02-25 | 1995-01-18 | 住友セメント株式会社 | Cosmetics |
GB9121143D0 (en) * | 1991-10-04 | 1991-11-13 | Tioxide Chemicals Limited | Dispersions |
GB9121153D0 (en) * | 1991-10-04 | 1991-11-13 | Tioxide Chemicals Ltd | Method of preparing sunscreens |
JP2697999B2 (en) * | 1992-06-29 | 1998-01-19 | 株式会社 フィルインターナショナル | Cosmetics |
CH684387A5 (en) * | 1993-04-22 | 1994-09-15 | Greiter Ag | Cosmetic or pharmaceutical product for topical application to the skin and the mucous membranes |
US5441726A (en) * | 1993-04-28 | 1995-08-15 | Sunsmart, Inc. | Topical ultra-violet radiation protectants |
US5663213A (en) * | 1994-02-28 | 1997-09-02 | Rohm And Haas Company | Method of improving ultraviolet radiation absorption of a composition |
WO2001013874A1 (en) * | 1999-08-19 | 2001-03-01 | Shiseido Co., Ltd. | Cosmetic sunscreen preparation |
JP4011799B2 (en) * | 1999-08-19 | 2007-11-21 | 株式会社資生堂 | Sunscreen cosmetics |
JP2008248043A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | Allergen inactivator and allergen inactivating product comprising the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57120514A (en) * | 1981-01-20 | 1982-07-27 | Pola Chem Ind Inc | Cosmetic having ultraviolet light shielding effect |
JPS57205319A (en) * | 1981-06-15 | 1982-12-16 | Mitsubishi Metal Corp | Manufacture of very fine zinc oxide powder |
JPS57209824A (en) * | 1981-06-16 | 1982-12-23 | Mitsubishi Metal Corp | Preparation of skin-colored fine zinc oxide powder |
JPS5962517A (en) * | 1982-10-04 | 1984-04-10 | Shiseido Co Ltd | Anti-suntan cosmetic |
JPS60231607A (en) * | 1984-04-28 | 1985-11-18 | Kobayashi Kooc:Kk | Antisuntan cosmetic |
-
1984
- 1984-07-31 JP JP16113484A patent/JPS6137711A/en active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57120514A (en) * | 1981-01-20 | 1982-07-27 | Pola Chem Ind Inc | Cosmetic having ultraviolet light shielding effect |
JPS57205319A (en) * | 1981-06-15 | 1982-12-16 | Mitsubishi Metal Corp | Manufacture of very fine zinc oxide powder |
JPS57209824A (en) * | 1981-06-16 | 1982-12-23 | Mitsubishi Metal Corp | Preparation of skin-colored fine zinc oxide powder |
JPS5962517A (en) * | 1982-10-04 | 1984-04-10 | Shiseido Co Ltd | Anti-suntan cosmetic |
JPS60231607A (en) * | 1984-04-28 | 1985-11-18 | Kobayashi Kooc:Kk | Antisuntan cosmetic |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008273767A (en) * | 2007-04-26 | 2008-11-13 | Sakai Chem Ind Co Ltd | Method for producing zinc oxide and zinc oxide |
Also Published As
Publication number | Publication date |
---|---|
JPS6137711A (en) | 1986-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6132739A (en) | Makeup compositions and methods of making same | |
AU708824B2 (en) | Topical vehicles containing solubilized and stabilized azelaic acid | |
US5904918A (en) | Cosmetic powder composition | |
JPH0577644B2 (en) | ||
US6309627B1 (en) | Cosmetic compositions with agglomerated substrates | |
JP2670812B2 (en) | Liquid cosmetics | |
JPH10158115A (en) | Cosmetic | |
US5667772A (en) | Preparation containing a fluorocarbon emulsion and usable as cosmetics or dermatics | |
CA1091585A (en) | Triethanolamine lauryl sulfate, encapsulated oil and a thickener as shampoo-hair conditioner | |
JP2001058935A (en) | Production of dispersed composition for cosmetic | |
JPH07502757A (en) | Preparations containing fluorocarbon emulsions that can be used as cosmetics or dermatological drugs | |
JP2000309503A (en) | Liquid or creamy cosmetic containing cellulose fine particle | |
JP3242137B2 (en) | Oil-in-water solid cosmetics | |
JPH09235217A (en) | Inorganic powder material and cosmetic using the same | |
JP3288765B2 (en) | Aqueous powdered cosmetics | |
JPH09263523A (en) | Sunscreen cosmetic | |
KR20180031173A (en) | Make-up cosmetic composition comprising scoria powder | |
KR101684415B1 (en) | Cosmetic composition of water-in-oil with liposome hexacarboxymethyl dipeptide-12 and menufacturing method thereof | |
JP4516729B2 (en) | Iron phosphate-containing composite and cosmetic containing the same | |
JPH10212224A (en) | Sunscreen cosmetic | |
JPH11130680A (en) | Preparation for external use for skin | |
JP2002265342A (en) | Ultraviolet protecting cosmetic | |
JPH083026A (en) | Cosmetic | |
JPS6239517A (en) | Cosmetic | |
JP2001048731A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |